Natac Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 103
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 4
  • Investments
  • 1

Natac General Information

Description

Producer of herbal extracts with a focus on the olive tree and grapevine-derived ingredients intended to help users improve their life. The company is engaged in researching, developing, manufacturing, and marketing ingredients of natural origin, mainly plant extracts, for the following markets as pharmaceutical, nutraceutical, food, feed and cosmetics, enabling users to apply the benefits of nature through scientific knowledge.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Multi-line Chemicals
Primary Office
  • C / Electrónica 7
  • Alcorcón
  • 28923 Madrid
  • Spain
+34 918 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Natac Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Natac‘s full profile, request access.

Request a free trial

Natac Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Producer of herbal extracts with a focus on the olive tree and grapevine-derived ingredients intended to help users impr
Biotechnology
Madrid, Spain
103 As of 2021
00000
0000 0000-00-00
0000000 0000 00000

0000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
000000000000000
Mollet del Vallès, Spain
000 As of 0000
0000 0000-00-00
000000&0

0000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
00000 00000000 000-00000000
Avignon, France
0000 As of 0000
000.00
0.000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Natac Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Euromed Formerly PE-Backed Mollet del Vallès, Spain 000 000000&0
0000000 Corporate Backed or Acquired Avignon, France 0000 000.00 000000&0 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Natac Executive Team (7)

Name Title Board Seat Contact Info
Antonio Delgado Co-Founder, Chief Executive Officer & Board Member
José Quintela Ph.D Co-Founder, Chief Scientific Officer & Board Member
Gemma Vernet Finance Director
Carmen Nuevo Quality Assurance Manager
You’re viewing 4 of 7 executive team members. Get the full list »

Natac Board Members (2)

Name Representing Role Since
0000000 0000000 Natac Co-Founder, Chief Executive Officer & Board Member 000 0000
000é 00000000 00.0 Natac Co-Founder, Chief Scientific Officer & Board Member 000 0000
To view Natac’s complete board members history, request access »

Natac Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Natac Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Natac‘s full profile, request access.

Request a free trial

Natac Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000 07-Nov-2018 00000 0000000 Other Healthcare Services 0000000 0000000
To view Natac’s complete investments history, request access »